Julie May
Pediatrics · Oklahoma City, OKNPI 1407048119
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,396 of the $5,355 with a category attached, or 82.1%. 34 manufacturers reported payments, led by Livanova USA, Inc. at 30.0% of the total. Reporting peaked in 2023 at $2,247 and has fallen 58.8% since, to $925 in 2025. Among pediatrics clinicians in OK with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 194 payments — averaging $27.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Livanova USA, Inc.$2K
- UCB, Inc.$1K
- Neurelis, Inc.$439
- Jazz Pharmaceuticals Inc.$366
- Immedica Pharma US, Inc.$235
- Catalyst Pharmaceuticals, Inc.$199
- plus $1K from 28 others
What the payments were for
- Travel & lodging$95918%
- Food & beverage$4,39682%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Livanova USA, Inc. | 13 | $1,604 |
| UCB, Inc. | 56 | $1,113 |
| Neurelis, Inc. | 22 | $439 |
| Jazz Pharmaceuticals Inc. | 15 | $366 |
| Immedica Pharma US, Inc. | 8 | $235 |
| Catalyst Pharmaceuticals, Inc. | 10 | $199 |
| Eisai Inc. | 11 | $180 |
| Acadia Pharmaceuticals Inc | 8 | $171 |
| Xeris Pharmaceuticals, Inc. | 6 | $129 |
| Servier Pharmaceuticals LLC | 1 | $110 |
| Supernus Pharmaceuticals, Inc. | 6 | $96 |
| SK Life Science, Inc. | 4 | $89 |
| Biomarin Pharmaceutical Inc. | 3 | $66 |
| Regeneron Healthcare Solutions, Inc. | 3 | $53 |
| Tolmar, Inc. | 2 | $47 |
| Aquestive Therapeutics, Inc. | 3 | $45 |
| Biogen | 2 | $40 |
| Upsher-smith Laboratories LLC | 2 | $38 |
| NS Pharma, Inc. | 2 | $31 |
| Vanda Pharmaceuticals Inc. | 2 | $29 |
| Eton Pharmaceuticals, Inc. | 1 | $25 |
| Amneal Pharmaceuticals LLC | 2 | $23 |
| Teva Pharmaceuticals USA, Inc. | 1 | $23 |
| Tandem Diabetes Care, Inc. | 1 | $23 |
| Novo Nordisk | 1 | $22 |
| AstraZeneca | 1 | $21 |
| Genentech USA, Inc. | 1 | $20 |
| Tolmar Pharmaceuticals, Inc. | 1 | $19 |
| Abbott | 1 | $18 |
| AbbVie | 1 | $18 |
| Nestle Healthcare Nutrition Inc. | 1 | $17 |
| Sanofi | 1 | $17 |
| Lilly USA, LLC | 1 | $15 |
| Tris Pharma Inc | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- VNS Therapy$1,359
How this compares
$5,355 in reported general payments places this provider in the 95th percentile of 568 pediatrics providers in Oklahoma.
Other pediatrics in Oklahoma City
- Scott MelsonOklahoma City$11K
- Rachel SpragueOklahoma City$4K
- Brittany FarquharOklahoma City$3K
- Hamed AlbiekOklahoma City$3K
- Branson KesterOklahoma City$3K
- Stephanie GrimOklahoma City$2K
- Diana FarrowOklahoma City$2K
- Robert MooreOklahoma City$2K
- Jordan PopeOklahoma City$2K
- Jennifer CooperOklahoma City$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.